Build Strategies for
Pre- and Post-Launch
Looking to level up your launch strategy? Start here.
MMIT’s suite of data products helps pharma companies get their drugs to market, ensure patients can access them, and accurately forecast payer and patient uptake. We leverage NorstellaLinQ data to offer you a 360-degree view into the patient journey, revealing the barriers to be overcome. We help you improve payer coverage, influence product positioning, and facilitate easier patient access.
Make Better Decisions With Complete Coverage Data
Our Analytics solution delivers the most comprehensive formulary, medical policy and restriction information to help you evaluate patient access for your brand and competitors. Anticipate market share shifts with payer and PBM data analysis.
Overcome Access Barriers With Real-World Insights
MMIT’s RWD Visualizations solution combines coverage data and claims data to provide commercial pharma teams with a unique view of payer and prescriber behavior.
Transform Real-World Data Into Actionable Insights
Use Norstella proprietary datasets to evaluate key business questions and objectives, conduct deeper data, and create a report with insights layered into each analysis and the overall implications to your strategy.
Support Effective IDN Segmentation and Targeting
Our IDN Formulary Insights solution provides unparalleled visibility into health system formularies, clinical pathways, decision-making and contracting. Optimize your resources and improve your account-level strategies.
Predict Payer Uptake of New Drugs
Our Strategic Launch Report provides payers’ coverage and utilization management adoption rates within the first year. Plan ahead with Evaluate’s consensus forecast data for approved and pipeline agents in your therapeutic area.
From Noise to Clarity in 48 Hours or Less
Searchlight delivers policy change alerts within 24-48 hours, as well as AI-powered policy summaries, clear visual comparisons, and user-level personalization to turn noisy policy updates into targeted, strategic insights.